Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.58 |
| ▸ | NAMPT | P43490 | 1/20 | 0.58 |
| ▸ | XDH | P47989 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.47 |
| ▸ | PARP1 | P09874 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 5/20 | 0.40 |
| ▸ | MEN1 | O00255 | 4/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | GRIA1 | P42261 | 2/20 | 0.39 |
| ▸ | GRIA2 | P42262 | 2/20 | 0.39 |
| ▸ | GRIA3 | P42263 | 2/20 | 0.39 |
| ▸ | GRIA4 | P48058 | 2/20 | 0.39 |
| ▸ | KIF11 | P52732 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 3/20 | 0.38 |
| ▸ | MAOB | P27338 | 1/20 | 0.38 |
| ▸ | NOS1 | P29475 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoromethanesulfonic Acid SCHEMBL18169501 | 1.00 | CYP3A4 (0.58) | CYP3A4NAMPTXDHALDH1A1PARP1 | |
| Trifluoromethanesulfonic Acid SCHEMBL18169502 | 0.91 | CYP3A4 (0.73) | CYP3A4NAMPTXDHALDH1A1PARP1 | |
| Benzimidazole SCHEMBL28288616 | 0.88 | CYP3A4 (0.64) | CYP3A4NAMPTXDHALDH1A1PARP1 | |
| Nitric Acid SCHEMBL4907401 | 0.87 | CYP3A4 (0.71) | CYP3A4NAMPTXDHALDH1A1PARP1 | |
| SCHEMBL29923659 | 0.86 | CYP3A4 (0.77) | CYP3A4NAMPTXDHALDH1A1PARP1 | |
| SCHEMBL271340 | 0.86 | CYP3A4 (0.77) | CYP3A4NAMPTXDHALDH1A1PARP1 | |
| SCHEMBL8425555 | 0.84 | CYP3A4 (0.75) | CYP3A4NAMPTXDHALDH1A1PARP1 | |
| Silver SCHEMBL11230934 | 0.84 | CYP3A4 (0.75) | CYP3A4NAMPTXDHALDH1A1PARP1 | |
| Alcohol SCHEMBL28252889 | 0.81 | CYP3A4 (0.65) | CYP3A4NAMPTXDHALDH1A1PARP1 | |
| Acetic Acid SCHEMBL28050837 | 0.81 | CYP3A4 (0.65) | CYP3A4NAMPTXDHALDH1A1PARP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 112 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260125414-A1 | PRODUCTION METHOD OF OLIGONUCLEOTIDE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2026-05-07 | — | — | US | disclosed |
| EP-4151597-B1 | INORGANIC POROUS SUBSTRATE, INORGANIC POROUS SUPPORT, AND NUCLEIC ACID PRODUCTION METHOD | SUMITOMO CHEMICAL CO (JP) | 2026-04-15 | — | — | EP | disclosed |
| EP-4137500-B1 | METHOD FOR PRODUCING NUCLEIC ACID OLIGOMER | SUMITOMO CHEMICAL CO (JP) | 2026-03-11 | — | — | EP | disclosed |
| US-12540156-B2 | Method for producing nucleic acid oligomer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2026-02-03 | — | — | US | disclosed |
| US-12522629-B2 | Method for producing nucleic acid oligomer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2026-01-13 | — | — | US | disclosed |
| US-12509483-B2 | Method for producing nucleic acid oligomers | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2025-12-30 | — | — | US | disclosed |
| US-12509485-B2 | Method for producing nucleic acid oligomer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2025-12-30 | — | — | US | disclosed |
| EP-4644404-A1 | OLIGONUCLEOTIDE PRODUCTION METHOD | Sumitomo Chemical Company, Limited (JP) | 2025-11-05 | — | — | EP | disclosed |
| US-12391716-B2 | Process of preparing nucleic acid oligomer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2025-08-19 | — | — | US | disclosed |
| US-12377409-B2 | Inorganic porous carrier, and production method for nucleic acid using same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2025-08-05 | — | — | US | disclosed |
| US-10253153-B2 | Linker and support for solid phase synthesis of nucleic acid, and production method of nucleic acid using said support | NITTO DENKO CORPORATION (JP) | 2019-04-09 | — | — | US | disclosed |
| WO-2018019748-A1 | 5'S-LNA NUCLEOTIDES AND OLIGONUCLEOTIDES | F. HOFFMANN-LA ROCHE AG (CH) | 2018-02-01 | — | — | WO | disclosed |
| US-20160311847-A1 | LINKER AND SUPPORT FOR SOLID PHASE SYNTHESIS OF NUCLEIC ACID, AND PRODUCTION METHOD OF NUCLEIC ACID USING SAID SUPPORT | NITTO DENKO CORPORATION (JP) | 2016-10-27 | — | — | US | disclosed |
| EP-2620444-B1 | Linker and support for solid phase synthesis of nucleic acid | NITTO DENKO CORP (JP) | 2015-05-06 | — | — | EP | disclosed |
| US-8835656-B2 | Linker and support for solid phase synthesis of nucleic acid | NITTO DENKO CORPORATION (JP) | 2014-09-16 | — | — | US | disclosed |
| US-8669356-B2 | Linker and support for solid phase synthesis of nucleic acid | NITTO DENKO CORPORATION (JP) | 2014-03-11 | — | — | US | disclosed |
| US-20130197117-A1 | LINKER AND SUPPORT FOR SOLID PHASE SYNTHESIS OF NUCLEIC ACID | NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) | 2013-08-01 | — | — | US | disclosed |
| EP-2620444-A1 | Linker and Support for Solid Phase Synthesis of Nucleic Acid | Nitto Denko Corporation (JP) | 2013-07-31 | — | — | EP | disclosed |
| EP-2357188-A1 | Linker and support for solid phase synthesis of nucleic acid | Nitto Denko Corporation (JP) | 2011-08-17 | — | — | EP | disclosed |
| US-20110092690-A1 | LINKER AND SUPPORT FOR SOLID PHASE SYNTHESIS OF NUCLEIC ACID | NITTO DENKO CORPORATION (JP) | 2011-04-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260125414-A1 | PRODUCTION METHOD OF OLIGONUCLEOTIDE | NSUN2, DDX41, FBL | CYP3A4 1329/4885NAMPT 4362/4885XDH 374/4885 |
| US-12391716-B2 | Process of preparing nucleic acid oligomer | POLRMT, RNGTT, POLM | CYP3A4 2209/4885NAMPT 462/4885XDH 2629/4885 |
| US-12509483-B2 | Method for producing nucleic acid oligomers | POLM, RNGTT, POLRMT | CYP3A4 3968/4885NAMPT 3530/4885XDH 2199/4885 |
| US-10253153-B2 | Linker and support for solid phase synthesis of nucleic acid, and production method of nucleic acid using said support | RNGTT, NSUN2, NSUN3 | CYP3A4 3694/4885NAMPT 970/4885XDH 1609/4885 |
| US-12509485-B2 | Method for producing nucleic acid oligomer | RNGTT, POLM, NSUN2 | CYP3A4 3869/4885NAMPT 3681/4885XDH 1528/4885 |
| US-20160311847-A1 | LINKER AND SUPPORT FOR SOLID PHASE SYNTHESIS OF NUCLEIC ACID, AND PRODUCTION METHOD OF NUCLEIC ACID USING SAID SUPPORT | RNGTT, NSUN2, NSUN3 | CYP3A4 3694/4885NAMPT 970/4885XDH 1609/4885 |
| US-12540156-B2 | Method for producing nucleic acid oligomer | NSUN2, RNGTT, RNMT | CYP3A4 4846/4885NAMPT 3281/4885XDH 1849/4885 |
| US-20110092690-A1 | LINKER AND SUPPORT FOR SOLID PHASE SYNTHESIS OF NUCLEIC ACID | RNGTT, NSUN2, SSU72 | CYP3A4 4224/4885NAMPT 919/4885XDH 2008/4885 |
| US-12377409-B2 | Inorganic porous carrier, and production method for nucleic acid using same | SLCO2A1, SLCO2B1, SLCO1A2 | CYP3A4 3692/4885NAMPT 3949/4885XDH 3061/4885 |
| US-20130197117-A1 | LINKER AND SUPPORT FOR SOLID PHASE SYNTHESIS OF NUCLEIC ACID | SSU72, NSUN2, RNGTT | CYP3A4 3603/4885NAMPT 1554/4885XDH 1499/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.